Apollo Hospitals Enterprise Limited
APOLLOHOSP · 508869 · Healthcare · Hospital
- Market cap
- Rs 1,17,916 Cr
- P/E
- 56.42x
- P/B
- 12.44x
- 52W high / low
- Rs 9,070.5 / Rs 6,696.5
Our computed operating_margin (12.46%) diverges from BSE's own published figure (28.12%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
About Apollo Hospitals Enterprise
Apollo Hospitals Enterprise Limited is listed on the NSE under the symbol APOLLOHOSP and on the BSE under scrip code 508869. It is classified in the Healthcare sector, industry: Hospital. It is a constituent of BSE 100, NIFTY 100, NIFTY 200, NIFTY 50 and NIFTY 500. The company listed on 10 Jan 1996 and has a face value of Rs 5.
The latest available end-of-day price is Rs 8,200 (+0.77% on the day), for a market capitalisation of Rs 1,17,916 Cr. Trailing P/E is 56.42x and price-to-book is 12.44x. The 52-week range is Rs 6,696.5 to Rs 9,070.5. The latest price is 63% of the way from the 52-week low to the 52-week high.
Against the 10-company comparison set from the official BSE basic industry Hospital, its market capitalisation is 3.4 times the peer median of Rs 35,038 Cr, and its P/E of 56.42x compares with a peer median of 56.60x. The comparison set is chosen mechanically from the exchange classification; it is not a ranking.
Latest annual results
For FY26 (year ended 31 Mar 2026), Apollo Hospitals Enterprise Limited reported revenue of Rs 25,229 Cr and net profit of Rs 2,003 Cr, with a net margin of 7.94% and earnings per share of Rs 135.04 (consolidated statements).
Year-on-year change: revenue +15.58%; net profit +33.06%; EPS +34.29%. Three-year compound annual growth rate: revenue +15.02%; net profit +33.34%.
At the same date the balance sheet shows total assets of Rs 22,197 Cr, shareholders' equity of Rs 9,480 Cr, total debt of Rs 5,659 Cr, cash of Rs 811 Cr, a debt-to-equity ratio of 0.60 and operating cash flow of Rs 2,856 Cr.
On a trailing-twelve-month basis the filings add up to revenue of Rs 26,430 Cr, net income of Rs 2,172 Cr and a net margin of 8.22%.
Shareholding pattern
In the shareholding pattern for 30 Sept 2026, Apollo Hospitals Enterprise Limited's ownership is split: promoters 28.02%; foreign institutional investors (FIIs) 43.18%; domestic institutional investors (DIIs) 22.07%; retail and other shareholders 6.73%.
Compared with the filing for 30 Jun 2026: promoter holding 0.00 percentage points; FII holding +1.68 percentage points; DII holding −1.65 percentage points.
The same filing lists reported promoter pledge of 2.91% and 1,72,863 shareholders on record.
Recent filings and corporate actions
89 BSE corporate announcements were filed by Apollo Hospitals Enterprise Limited in the past twelve months; the most frequent category is "Company Update" (58). The most recent is "As per annexure enclosed" (Company Update), filed on 16 Oct 2026.
The disclosed corporate-action timeline lists 9 entries: dividend (9). The latest is a dividend (Final Dividend - Rs. - 10.0000) with ex-date 14 Aug 2026.
Figures are raw disclosures from official NSE/BSE and SEBI filings plus mechanically computed ratios, restated in words. This is research data, not investment advice, a rating or a recommendation; DalalOS is not a SEBI-registered investment advisor.
More
Peer comparison
Official BSE basic industry: Hospital. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Apollo Hospitals Enterprise LimitedThis company | Rs 8,200 | Rs 1,17,916 Cr | Rs 26,630 Cr | Rs 2,172 Cr | 56.42x | 23.62% |
| Max Healthcare Institute Limited | Rs 851.15 | Rs 82,837 Cr | Rs 8,879 Cr | Rs 1,457 Cr | 56.78x | 14.48% |
| Manipal Health Enterprises Limited | Rs 638.8 | Rs 75,362 Cr | — | — | 82.85x | — |
| Fortis Healthcare Limited | Rs 754.9 | Rs 56,992 Cr | Rs 9,556 Cr | Rs 1,070 Cr | 54.39x | 11.14% |
| Aster DM Quality Care Limited | Rs 679.2 | Rs 35,191 Cr | Rs 5,005 Cr | Rs 363 Cr | 90.20x | 7.96% |
| Narayana Hrudayalaya Ltd. | Rs 1,714.5 | Rs 35,038 Cr | Rs 9,184 Cr | Rs 817 Cr | 42.41x | 19.99% |
| Global Health Limited | Rs 1,299.7 | Rs 34,932 Cr | Rs 4,784 Cr | Rs 552 Cr | 62.79x | 15.14% |
| Krishna Institute of Medical Sciences Limited | Rs 702.5 | Rs 29,505 Cr | Rs 4,248 Cr | Rs 194 Cr | — | 9.33% |
| Dr. Agarwal's Health Care Limited | Rs 488.7 | Rs 15,492 Cr | Rs 2,244 Cr | Rs 185 Cr | 83.70x | 7.62% |
| Rainbow Childrens Medicare Limited | Rs 1,196.8 | Rs 12,155 Cr | Rs 1,857 Cr | Rs 290 Cr | 42.58x | 18.32% |
| Median | Rs 851.15 | Rs 35,038 Cr | Rs 6,831 Cr | Rs 684 Cr | 56.60x | 14.81% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Companies related to Apollo Hospitals Enterprise
Same official industry (Hospital)
- Max Healthcare Institute LimitedMAXHEALTH · Market cap Rs 82,837 Cr
- Manipal Health Enterprises LimitedMANIPALHOS · Market cap Rs 75,362 Cr
- Fortis Healthcare LimitedFORTIS · Market cap Rs 56,992 Cr
- Aster DM Quality Care LimitedASTERDM · Market cap Rs 35,191 Cr
- Narayana Hrudayalaya Ltd.NH · Market cap Rs 35,038 Cr
- Global Health LimitedMEDANTA · Market cap Rs 34,932 Cr
- Krishna Institute of Medical Sciences LimitedKIMS · Market cap Rs 29,505 Cr
- Dr. Agarwal's Health Care LimitedAGARWALEYE · Market cap Rs 15,492 Cr
Other Healthcare companies of a similar market capitalisation
- Torrent Pharmaceuticals LimitedTORNTPHARM · Market cap Rs 1,55,015 Cr
- Laurus Labs LimitedLAURUSLABS · Market cap Rs 1,21,232 Cr
- Zydus Lifesciences LimitedZYDUSLIFE · Market cap Rs 1,18,203 Cr
- Dr. Reddy's Laboratories LimitedDRREDDY · Market cap Rs 1,12,308 Cr
- Cipla LimitedCIPLA · Market cap Rs 1,09,706 Cr
- Mankind Pharma LimitedMANKIND · Market cap Rs 1,01,982 Cr
- Aurobindo Pharma LimitedAUROPHARMA · Market cap Rs 95,511 Cr
- Lupin LimitedLUPIN · Market cap Rs 90,988 Cr
Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.